KING PHARMACEUTICALS INC
S-4, EX-99.3, 2000-07-28
PHARMACEUTICAL PREPARATIONS
Previous: KING PHARMACEUTICALS INC, S-4, EX-99.2, 2000-07-28
Next: KING PHARMACEUTICALS INC, S-4, EX-99.4, 2000-07-28



<PAGE>   1
                                                                    EXHIBIT 99.3

                           CONSENT OF G. ANDREW FRANZ

hereby consent to being named a director of King Pharmaceuticals, Inc. in the
event the merger is consummated as disclosed in the Registration of King
Pharmaceuticals, Inc. on Form S-4, filed with the Securities and Exchange
Commission on July 27, 2000.


                                                       /s/ G. ANDREW FRANZ
                                                       -------------------------
                                                       G. Andrew Franz

                                                       July 27, 2000


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission